BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 25438085)

  • 1. Efficacious gene silencing in serum and significant apoptotic activity induction by survivin downregulation mediated by new cationic gemini tocopheryl lipids.
    Kumar K; Maiti B; Kondaiah P; Bhattacharya S
    Mol Pharm; 2015 Feb; 12(2):351-61. PubMed ID: 25438085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient Cellular Knockdown Mediated by siRNA Nanovectors of Gemini Cationic Lipids Having Delocalizable Headgroups and Oligo-Oxyethylene Spacers.
    Martínez-Negro M; Kumar K; Barrán-Berdón AL; Datta S; Kondaiah P; Junquera E; Bhattacharya S; Aicart E
    ACS Appl Mater Interfaces; 2016 Aug; 8(34):22113-26. PubMed ID: 27508330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syntheses, transfection efficacy and cell toxicity properties of novel cholesterol-based gemini lipids having hydroxyethyl head group.
    Biswas J; Mishra SK; Kondaiah P; Bhattacharya S
    Org Biomol Chem; 2011 Jun; 9(12):4600-13. PubMed ID: 21537498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfection efficiencies of α-tocopherylated cationic gemini lipids with hydroxyethyl bearing headgroups under high serum conditions.
    Maiti B; Kamra M; Karande AA; Bhattacharya S
    Org Biomol Chem; 2018 Mar; 16(11):1983-1993. PubMed ID: 29498723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacious redox-responsive gene delivery in serum by ferrocenylated monomeric and dimeric cationic cholesterols.
    Vulugundam G; Kumar K; Kondaiah P; Bhattacharya S
    Org Biomol Chem; 2015 Apr; 13(14):4310-20. PubMed ID: 25762431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-Tocopherol derived lipid dimers as efficient gene transfection agents. Mechanistic insights into lipoplex internalization and therapeutic induction of apoptotic activity.
    Kumar K; Maiti B; Kondaiah P; Bhattacharya S
    Org Biomol Chem; 2015 Feb; 13(8):2444-52. PubMed ID: 25563750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
    Spagnou S; Miller AD; Keller M
    Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-targeted liposome-peptide nanocomplexes for siRNA delivery.
    Tagalakis AD; He L; Saraiva L; Gustafsson KT; Hart SL
    Biomaterials; 2011 Sep; 32(26):6302-15. PubMed ID: 21624650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of VEGF expression in A431 and MDA-MB-231 tumour cells by cationic lipid-mediated siRNA delivery.
    Briane D; Slimani H; Tagounits A; Naejus R; Haddad O; Coudert R; Charnaux N; Cao A
    J Drug Target; 2012 May; 20(4):347-54. PubMed ID: 22475204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient down-regulation of CDK4 by novel lipid nanoparticle-mediated siRNA delivery.
    Wang X; Yu B; Wu Y; Lee RJ; Lee LJ
    Anticancer Res; 2011 May; 31(5):1619-26. PubMed ID: 21617218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of lipoplex surface charge on siRNA delivery: application to the in vitro downregulation of CXCR4 HIV-1 co-receptor.
    Lavigne C; Slater K; Gajanayaka N; Duguay C; Arnau Peyrotte E; Fortier G; Simard M; Kell AJ; Barnes ML; Thierry AR
    Expert Opin Biol Ther; 2013 Jul; 13(7):973-85. PubMed ID: 23289797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
    Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
    J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small interfering RNA-mediated suppression of serum response factor, E2-promotor binding factor and survivin in non-small cell lung cancer cell lines by non-viral transfection.
    Walker T; Nolte A; Steger V; Makowiecki C; Mustafi M; Friedel G; Schlensak C; Wendel HP
    Eur J Cardiothorac Surg; 2013 Mar; 43(3):628-33; discussion 633-4. PubMed ID: 23152437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [RNAi-mediated gene silencing of livin synergistic with epirubicin enhance apoptosis of human breast cancer cells].
    Liang CY; Ma P; Liu XL
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1703-6. PubMed ID: 19024543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene-silencing effects of anti-survivin siRNA delivered by RGDV-functionalized nanodiamond carrier in the breast carcinoma cell line MCF-7.
    Bi Y; Zhang Y; Cui C; Ren L; Jiang X
    Int J Nanomedicine; 2016; 11():5771-5787. PubMed ID: 27853365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted lipoplexes for siRNA delivery.
    Cardoso A; Trabulo S; Moreira JN; Düzgüneş N; de Lima MC
    Methods Enzymol; 2009; 465():267-87. PubMed ID: 19913172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survivin downregulation by siRNA/cationic liposome complex radiosensitises human hepatoma cells in vitro and in vivo.
    Yang W; Sun T; Cao J; Liu F
    Int J Radiat Biol; 2010 Jun; 86(6):445-57. PubMed ID: 20470195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional nanocarrier based on clay nanotubes for efficient intracellular siRNA delivery and gene silencing.
    Wu H; Shi Y; Huang C; Zhang Y; Wu J; Shen H; Jia N
    J Biomater Appl; 2014 Apr; 28(8):1180-9. PubMed ID: 23985535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anionic amino acid-derived cationic lipid for siRNA delivery.
    Suh MS; Shim G; Lee HY; Han SE; Yu YH; Choi Y; Kim K; Kwon IC; Weon KY; Kim YB; Oh YK
    J Control Release; 2009 Dec; 140(3):268-76. PubMed ID: 19567256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of skin squamous cell carcinoma proliferation and promote apoptosis by dual silencing of NET-1 and survivin.
    Ji ZJ; Wang JL; Chen L
    Oncol Rep; 2015 Aug; 34(2):811-22. PubMed ID: 26080853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.